LGND
Ligand Pharmaceuticals IncorporatedNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.82B
P/E Ratio
37.90
EPS
$6.13
Beta
1.00
52W High
$247.38
52W Low
$98.89
50-Day MA
$207.99
200-Day MA
$185.57
Dividend Yield
—
Profit Margin
46.40%
Forward P/E
28.41
PEG Ratio
1.53
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $268.09M |
| Gross Profit (TTM) | $172.36M |
| EBITDA | $80.97M |
| Operating Margin | 33.60% |
| Return on Equity | 13.50% |
| Return on Assets | 2.36% |
| Revenue/Share (TTM) | $13.86 |
| Book Value | $51.44 |
| Price-to-Book | 2.88 |
| Price-to-Sales (TTM) | 10.51 |
| EV/Revenue | 9.8 |
| EV/EBITDA | 13.31 |
| Quarterly Earnings Growth (YoY) | 103.20% |
| Quarterly Revenue Growth (YoY) | 39.40% |
| Shares Outstanding | $12.13M |
| Float | $19.47M |
| % Insiders | 2.39% |
| % Institutions | 105.25% |
Historical Volatility
HV 10-Day
43.72%
HV 20-Day
47.20%
HV 30-Day
43.84%
HV 60-Day
39.38%
HV Rank
90.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($246.70 target)
2
Strong Buy7
BuyData last updated: 4/29/2026